MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
Journal Article

Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea

2012
Request Book From Autostore and Choose the Collection Method
Overview
Aim: To study whether epigallocatechin gallate (EGCG), a green tea-derived polyphenol, exerted anti-influenza A virus activity in vitro and in vivo. Methods: Madin-Darby canine kidney (MDCK) cells were tested. The antiviral activity of EGCG in the cells was determined using hemagglutination assay and qPCR. Time of addition assay was performed to determine the kinetics of inhibition of influenza A by EGCG. The level of reactive oxygen species (ROS) were determined with confocal microscopy and flow cytometry. BALB/c mice were treated with EGCG (10, 20 or 40 mg·kg-l·d-1, pc) for 5 d. On the 3rd d of the treatment, the mice were infected with influenza A virus. Histopathological changes, lung index and virus titers in the lungs were determined. Results: Treatment of influenza A-infected MDCK cells with EGCG (1.25-100 nmol/L) inhibited influenza A replication in a concen- tration-dependent manner (the EDso value was 8.71±1.11 nmol/L). Treatment with EGCG (20 nmol/L) significantly suppressed the increased ROS level in MDCK cells following influenza A infection. In BALB/c mice infected with influenza virus, oral administration of EGCG (40 mg·kg-1·d-1) dramatically improved the survival rate, decreased the mean virus yields and mitigated viral pneumonia in the lungs, which was equivalent to oral administration of oseltamivir (40 mg·kg-1·d-1), a positive control drug. Conclusion: The results provide a molecular basis for development of EGCG as a novel and safe chemopreventive agent for influenza A infection.